Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3692]

Trial indicates using atezolizumab with chemoradiation is safe and demonstrates signs of immune activation in women with cervical cancer

Trial indicates using atezolizumab with chemoradiation is safe and demonstrates signs of immune activation in...

Study reveals how to activate the immune system’s natural killer cells to protect against cancer and other diseases

Study reveals how to activate the immune system’s natural killer cells to protect against cancer and other diseases

Novel radioligand therapy proven superior for metastatic prostate cancer patients

Novel radioligand therapy proven superior for metastatic prostate cancer patients

A new approach for bolstering the ability of T cells to fight cancer

A new approach for bolstering the ability of T cells to fight cancer

Promising approach against treatment-resistant cancer

Promising approach against treatment-resistant cancer

Scientists uncover a new approach for treating aggressive cancer

Scientists uncover a new approach for treating aggressive cancer

Defeating leukaemia cells by depriving them of energy

Defeating leukaemia cells by depriving them of energy

ecancer are launching a new initiative to improve cancer care in low-income countries with support from Bristol Myers Squibb

ecancer are launching a new initiative to improve cancer care in low-income countries with support from Bristol...

The promise of PD-1 inhibition in relapsed cervical cancer

The promise of PD-1 inhibition in relapsed cervical cancer

Specific cancer driving protein plays important role in lung cancer development

Specific cancer driving protein plays important role in lung cancer development

More from ecancer